A randomised controlled trial of transdermal versus intramuscular testosterone therapy in transgender males
- Research Opportunity
- Number of Honour Places Available
- Medicine and Radiology
- Austin Health
|Prof Jeffrey Zajacfirstname.lastname@example.org||90357030||Personal web page|
|Dr Ada Cheungemail@example.com||Personal web page|
This is a randomised controlled trial comparing the safety of intramuscular vs transdermal testosterone on haematocrit in transgender males. Testosterone can increase haematocrit (blood thickness) and raised haematocrit levels have been associated with increased cardiovascular mortality, the risk of which is higher in biological females than biological males. It is uncertain whether haematocrit levels in transgender males are associated with adverse cardiovascular risk.
The project is based at Heidelberg Repatriation Hospital (part of Austin Health) within the Trans Medical Research Group, Endocrinology Department (Department of Medicine).
Faculty Research Themes
School Research Themes
Students who are interested in joining this project will need to consider their elegibility as well as other requirements before contacting the supervisor of this research
For further information about this research, please contact a supervisor.
Research Group / Unit / Centre
Research NodeAustin Health
MDHS Research library
Explore by researcher, school, project or topic.